vs
Side-by-side financial comparison of GSI TECHNOLOGY INC (GSIT) and Sunshine Biopharma Inc. (SBFM). Click either name above to swap in a different company.
Sunshine Biopharma Inc. is the larger business by last-quarter revenue ($8.6M vs $6.1M, roughly 1.4× GSI TECHNOLOGY INC). Sunshine Biopharma Inc. runs the higher net margin — -25.0% vs -49.7%, a 24.7% gap on every dollar of revenue. On growth, GSI TECHNOLOGY INC posted the faster year-over-year revenue change (12.2% vs -10.6%). Sunshine Biopharma Inc. produced more free cash flow last quarter ($-1.6M vs $-8.2M). Over the past eight quarters, GSI TECHNOLOGY INC's revenue compounded faster (8.6% CAGR vs 6.6%).
Triad GSI is an American voting machine vendor based in Xenia, Ohio. Their main products are election-related computer hardware and software for counting ballots, as well as voter registration.
Sunshine Biopharma Inc. is a clinical-stage biopharmaceutical company focused on researching, developing and commercializing innovative therapies for oncology, neurodegenerative disorders and infectious diseases. It targets unmet medical needs across global markets, with a pipeline of targeted therapeutic candidates designed to improve patient treatment outcomes.
GSIT vs SBFM — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $6.1M | $8.6M |
| Net Profit | $-3.0M | $-2.1M |
| Gross Margin | 52.7% | 35.3% |
| Operating Margin | -113.7% | -20.9% |
| Net Margin | -49.7% | -25.0% |
| Revenue YoY | 12.2% | -10.6% |
| Net Profit YoY | 25.0% | 0.8% |
| EPS (diluted) | $-0.09 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $6.1M | $8.6M | ||
| Q3 25 | $6.4M | $9.4M | ||
| Q2 25 | $6.3M | $9.4M | ||
| Q1 25 | $5.9M | $8.9M | ||
| Q4 24 | $5.4M | $9.6M | ||
| Q3 24 | $4.5M | $8.4M | ||
| Q2 24 | $4.7M | $9.3M | ||
| Q1 24 | $5.2M | $7.5M |
| Q4 25 | $-3.0M | $-2.1M | ||
| Q3 25 | $-3.2M | $-883.8K | ||
| Q2 25 | $-2.2M | $-1.8M | ||
| Q1 25 | $-2.2M | $-1.2M | ||
| Q4 24 | $-4.0M | $-2.2M | ||
| Q3 24 | $-5.5M | $-1.2M | ||
| Q2 24 | $1.1M | $-494.3K | ||
| Q1 24 | $-4.3M | $-1.3M |
| Q4 25 | 52.7% | 35.3% | ||
| Q3 25 | 54.8% | 32.6% | ||
| Q2 25 | 58.1% | 36.4% | ||
| Q1 25 | 56.1% | 30.7% | ||
| Q4 24 | 54.0% | 32.2% | ||
| Q3 24 | 38.6% | 34.0% | ||
| Q2 24 | 46.3% | 25.3% | ||
| Q1 24 | 51.6% | 31.2% |
| Q4 25 | -113.7% | -20.9% | ||
| Q3 25 | -49.5% | -11.5% | ||
| Q2 25 | -34.6% | -21.8% | ||
| Q1 25 | -38.7% | -14.6% | ||
| Q4 24 | -74.9% | -21.7% | ||
| Q3 24 | -122.7% | -13.1% | ||
| Q2 24 | 23.1% | -13.6% | ||
| Q1 24 | -87.6% | -17.9% |
| Q4 25 | -49.7% | -25.0% | ||
| Q3 25 | -49.4% | -9.4% | ||
| Q2 25 | -35.3% | -18.8% | ||
| Q1 25 | -37.9% | -13.3% | ||
| Q4 24 | -74.4% | -22.5% | ||
| Q3 24 | -120.0% | -14.2% | ||
| Q2 24 | 23.1% | -5.3% | ||
| Q1 24 | -83.9% | -17.0% |
| Q4 25 | $-0.09 | — | ||
| Q3 25 | $-0.11 | $-0.54 | ||
| Q2 25 | $-0.08 | $-0.82 | ||
| Q1 25 | $-0.09 | $-0.44 | ||
| Q4 24 | $-0.16 | $49.77 | ||
| Q3 24 | $-0.21 | $-11.61 | ||
| Q2 24 | $0.04 | $-43.48 | ||
| Q1 24 | $-0.17 | $-2.00 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $70.7M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $83.6M | $23.0M |
| Total Assets | $98.5M | $30.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $70.7M | — | ||
| Q3 25 | $25.3M | — | ||
| Q2 25 | $22.7M | — | ||
| Q1 25 | $13.4M | — | ||
| Q4 24 | $15.1M | — | ||
| Q3 24 | $18.4M | — | ||
| Q2 24 | $21.8M | — | ||
| Q1 24 | $14.4M | — |
| Q4 25 | $83.6M | $23.0M | ||
| Q3 25 | $38.6M | $24.2M | ||
| Q2 25 | $37.4M | $25.7M | ||
| Q1 25 | $28.2M | $22.7M | ||
| Q4 24 | $29.9M | $23.5M | ||
| Q3 24 | $33.3M | $25.0M | ||
| Q2 24 | $38.0M | $23.5M | ||
| Q1 24 | $36.0M | $24.8M |
| Q4 25 | $98.5M | $30.1M | ||
| Q3 25 | $52.0M | $31.5M | ||
| Q2 25 | $50.5M | $32.0M | ||
| Q1 25 | $43.3M | $29.2M | ||
| Q4 24 | $44.1M | $30.6M | ||
| Q3 24 | $47.4M | $30.1M | ||
| Q2 24 | $52.3M | $29.3M | ||
| Q1 24 | $42.5M | $31.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-7.9M | $-1.6M |
| Free Cash FlowOCF − Capex | $-8.2M | $-1.6M |
| FCF MarginFCF / Revenue | -134.4% | -18.9% |
| Capex IntensityCapex / Revenue | 4.9% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-12.5M | $-5.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-7.9M | $-1.6M | ||
| Q3 25 | $-887.0K | $-727.8K | ||
| Q2 25 | $-1.7M | $-1.3M | ||
| Q1 25 | $-1.7M | $-1.7M | ||
| Q4 24 | $-3.6M | $-3.4M | ||
| Q3 24 | $-3.5M | $-1.4M | ||
| Q2 24 | $-4.3M | $-4.6M | ||
| Q1 24 | $-7.1M | $-3.2M |
| Q4 25 | $-8.2M | $-1.6M | ||
| Q3 25 | $-906.0K | $-735.8K | ||
| Q2 25 | $-1.7M | $-1.4M | ||
| Q1 25 | $-1.7M | $-1.7M | ||
| Q4 24 | $-3.6M | $-3.5M | ||
| Q3 24 | $-3.5M | $-1.9M | ||
| Q2 24 | $-4.3M | $-5.6M | ||
| Q1 24 | $-7.2M | $-3.2M |
| Q4 25 | -134.4% | -18.9% | ||
| Q3 25 | -14.1% | -7.8% | ||
| Q2 25 | -27.6% | -15.2% | ||
| Q1 25 | -28.3% | -19.3% | ||
| Q4 24 | -66.1% | -36.6% | ||
| Q3 24 | -76.6% | -22.2% | ||
| Q2 24 | -92.0% | -59.7% | ||
| Q1 24 | -139.0% | -43.1% |
| Q4 25 | 4.9% | 0.0% | ||
| Q3 25 | 0.3% | 0.1% | ||
| Q2 25 | 0.3% | 1.7% | ||
| Q1 25 | 0.1% | 0.1% | ||
| Q4 24 | 0.1% | 1.1% | ||
| Q3 24 | 0.1% | 6.1% | ||
| Q2 24 | 0.7% | 10.5% | ||
| Q1 24 | 0.2% | 0.8% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -3.96× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GSIT
| Distribution | $5.6M | 92% |
| Other | $459.0K | 8% |
SBFM
Segment breakdown not available.
